0 Ask Account
Ask

Oral contraceptives and fatal pulmonary embolism

Peter Herbison, Lianne Parkin, C Paul, M Wilson, G P Herbison, D C Skegg

Author affiliations
  • University of Otago ROR

Lancet (London, England), 355(9221), 2133-2134, 2000

DOI 10.1016/S0140-6736(00)02382-5 PMID 10902629

Abstract

In a national case-control study of fatal pulmonary embolism in New Zealand women of childbearing age, we estimated that current users of combined oral contraceptives had a relative risk of 9.6 (95% CI 3.1-29.1). From national distribution data, the absolute risk of death from pulmonary embolism in current users was estimated to be 10.5 per million woman-years.

Topics

Contraception/Comparison > Oral Contraceptives > Venous ThromboembolismContraception/Comparison > Adverse Effects > Pulmonary Embolism MortalityResearch Methodology > Study Design > Case-Control Study
oral contraceptives fatal pulmonary embolism risk, combined oral contraceptive venous thromboembolism mortality, oral contraceptive pulmonary embolism case control study, birth control pill fatal blood clot risk women, oral contraceptive absolute risk pulmonary embolism per million, Parkin Skegg oral contraceptive pulmonary embolism New Zealand, combined oral contraceptives relative risk fatal embolism, hormonal contraception venous thromboembolism death risk, oral contraceptive cardiovascular mortality childbearing age, combined pill pulmonary embolism national case control
PMID 10902629 10902629 DOI 10.1016/S0140-6736(00)02382-5 10.1016/S0140-6736(00)02382-5

Cite this article

Parkin, L., Skegg, D. C., Wilson, M., Herbison, G. P., & Paul, C. (2000). Oral contraceptives and fatal pulmonary embolism. *Lancet (London, England)*, *355*(9221), 2133-2134. https://doi.org/10.1016/S0140-6736(00)02382-5

Keywords

Contraceptives, Oral

Related articles

Risk factors with breast cancer among women in Delhi
Pakseresht S et al., 2009 Indian Journal of Cancer

Background: The incidence of breast cancer is on the rise in India, breast cancer is the second most common malignancy in Indian women. Aim: The aim of this study was to find out the association of v...

General OB/GYN > Breast Health > Breast Cancer Risk FactorsContraception/Comparison > Risks and Side Effects > Breast CancerResearch Methodology > Study Design > Case-Control Study

Fracture risk in very young women using combined oral contraceptives
Vestergaard P et al., 2008 Contraception

Background: Little is known on fracture risk in young women using oral contraceptives. Study Design: Case-control study (64,548 cases, 193,641 controls). Results: Overall, no major association with ...

Contraception/Comparison > Side Effects > Fracture RiskBone Health > Oral Contraceptives > Young WomenResearch Methodology > Study Design > Case-Control Study

Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome
Warren JW et al., 2008 Urology

Objectives: Interstitial cystitis/painful bladder syndrome (IC/PBS) is a chronic disease primarily in women that is of low incidence and unknown etiology and manifests as bladder pain and urinary symp...

General OB/GYN > Urological Conditions > Interstitial CystitisDiagnostics > Urinary Analysis > UTI DetectionResearch Methodology > Study Design > Case-Control Study

Oral contraceptives and venous thromboembolism: a five-year national case-control study
Lidegaard Ø et al., 2002 Contraception

The objective of this study was to assess the influence of oral contraceptives (OCs) on the risk of venous thromboembolism (VTE) in young women. A 5-year case-control study including all Danish hospit...

Contraception/Comparison > Adverse Effects > Venous ThromboembolismContraception/Comparison > Oral Contraceptives > Progestin Generation ComparisonResearch Methodology > Study Design > Case-Control Study